Michael F. Hubank

Downs Road, Surrey
Sutton Upon Derwent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

Journal: European urology oncology

Published: May 05, 2026

A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.

A Delphi consensus for implementing genomic testing in unresectable or metastatic urothelial cancer.

Journal: BJU international

Published: April 27, 2026

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Journal: ESMO open

Published: March 24, 2026

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 08, 2025

Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants.

Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants.

Journal: British journal of haematology

Published: September 06, 2025

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Journal: Blood

Published: May 14, 2025

PLAG1-Rearranged Fibromyxoid and Lipomatous Neoplasms in Children and Adults: Separate Entities or a Morphological Spectrum?

PLAG1-Rearranged Fibromyxoid and Lipomatous Neoplasms in Children and Adults: Separate Entities or a Morphological Spectrum?

Journal: Genes, chromosomes & cancer

Published: May 05, 2025

MANIFEST: Multiomic Platform for Cancer Immunotherapy.

MANIFEST: Multiomic Platform for Cancer Immunotherapy.

Journal: Cancer discovery

Published: January 16, 2025

ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma.

ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma.

Journal: Cancer letters

Published: November 07, 2024

Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer.

Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer.

Journal: Journal of medical genetics

Published: October 08, 2024

Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

Journal: Cancer discovery

Published: June 27, 2024

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.

Journal: British journal of cancer

Published: May 10, 2024

Showing 1-12 of 59

Last Updated: 09/26/2026